Planned Parenthood likes to claim that abortion only makes up 3% of the “services” they provide, but according to Cate Dyer, the CEO of StemExpress, the abortion provider is a “volume business.”
The eighth Center for Medical Progress video exposing Planned Parenthood’s sale of aborted fetal body parts (made possible by Los Angeles Superior Court Judge Joanne O’Donnell’s ruling rejecting efforts by StemExpress to block the videos) shows Dyer admitting the company gets “a lot” of intact “cases.” CMP explains in its release that “case” is the clinical term for an individual abortion.
Because feticidal chemicals cannot be used to kill the fetus in tissue-procurement cases, it is highly likely that “a lot” of these infants are born alive and left to die on the on the abortionist’s table.
StemExpress is a for-profit biotech supply company that has been partnered with Planned Parenthood clinics across the country to purchase human fetal parts since its founding in 2010. StemExpress’ Medical Director, Dr. Ronald Berman, is an abortion doctor for Planned Parenthood Mar Monte.
In the video, actors posing as another human biologics company meet with StemExpress CEO Cate Dyer, plus Vice President of Corporate Development and Legal Affairs Kevin Cooksy, and Procurement Manager Megan Barr. StemExpress and the actors are discussing a potential partnership to supply extra fetal body parts to each other.
“So many physicians are like, ‘Oh I can totally procure tissue,’ and they can’t,” expresses Dyer, seeming to indicate that abortion doctors must do the procedure in a special way to obtain useable fetal parts. Federal law requires that no alteration in the timing or method of abortion be done for the purposes of fetal tissue collection (42 U.S.C. 289g-1).
“What about intact specimens?” asks one of the actors. “Oh yeah, I mean if you have intact cases, which we’ve done a lot, we sometimes ship those back to our lab in its entirety,” replies Dyer. “Case” is the clinical term for an abortion procedure. An “intact case” refers to an intact abortion with a whole fetus. “The entire case?” asks an actor. “Yeah, yeah,” says Dyer. “The procurement for us, I mean it can go really sideways, depending on the facility, and then our samples are destroyed,” she explains past botched fetal dissections, “so we started bringing them back even to manage it from a procurement expert standpoint.”
Feticidal chemicals like digoxin cannot be used to kill the fetus in a tissue procurement case, so a fetus delivered intact for organ harvesting is likely to be a born-alive infant.
“What would make your lab happy?” asks one of the actors. “Another 50 livers a week,” says Dyer. “We’re working with almost like triple digit number clinics,” Dyer explains, “and we still need more.” She later notes, “Planned Parenthood has volume, because they are a volume institution.”
Dyer also agrees that payments to abortion clinics for fetal body parts should be financially beneficial to them. “Do you feel like there are clinics out there that have been burned, that feel like they’re doing all this work for research and it hasn’t been profitable for them?” she asks. “I haven’t seen that.” StemExpress publishes a flyer for Planned Parenthood clinics that promises “Financial Profits” and “fiscal rewards” for clinics that supply aborted fetal tissue. It is endorsed by Planned Parenthood Mar Monte Chief Medical Officer Dr. Dorothy Furgerson.
The sale or purchase of human fetal tissue is a federal felony punishable by up to 10 years in prison or a fine of up to $500,000 (42 U.S.C. 289g-2). The Sacramento Business Journal reported in June that StemExpress has an annual revenue of $4.5 million.
According to a Washington Free Beacon report, a spokesman for StemExpress is claiming that Dyer wasn’t referring to fully intact aborted babies sold for research and that comments in other videos also referred to aborted baby body parts rather than fully intact babies.
“It would be upsetting, unnerving, and disturbing if they opened the box and saw what the result was” if researchers were not expecting a fetal organ delivery, the spokesman said.
“My use of the term ‘intact cases’ is a medical term of art that refers solely to ‘intact livers,’ as there was absolutely no mention of ‘intact fetuses’ at any point,” Dyer said in a company release. “Consistent with the company’s prior public statements, StemExpress has never requested, received or provided to a researcher an ‘intact fetus.’”
“The suction destroys everything and it gets to the point where I mean you could look at 60 cases and get nothing,” she said. “It’s just red water by the time it gets to us.”
In the 7th CMP video, released last week, StemExpress procurement technician Holly O’Donnell described an instance when she saw her supervisor tap the chest of “the most gestated fetus and closest thing to a baby I’ve seen,” and the heart started beating. She described another instance when she had trouble disposing of an aborted baby because he was so big. The baby’s body was almost too large to fit into the container, and O’Donnell had to work the feet that were dangling out, back inside.